J. Goldman & Co’s Alkermes ALKS Stock Holding History

J. Goldman & Co’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-75,000	Closed	-$1.4M	–	397
2021 Q1	$1.4M	Buy	+75,000	New	+$1.54M	0.05%	272
2017 Q2	–	Sell	-13,000	Closed	-$761K	–	295
2017 Q1	$761K	Buy	+13,000	New	+$737K	0.04%	266

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

J. Goldman & Co's ALKS Position: Q3 2025 in Review

J. Goldman & Co sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 21,425 shares — an estimated $613K sold.

J. Goldman & Co first reported a position in ALKS in Q1 2021 and held it in 5 quarters. The position peaked at $5.16M in Q2 2022. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

J. Goldman & Co reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
J. Goldman & Co sold 21,425 Alkermes shares in Q3 2025, an estimated $613K.
J. Goldman & Co first reported a position in Alkermes in Q1 2021 and held it in 5 quarters.
J. Goldman & Co's Alkermes position peaked at $5.16M in Q2 2022.
358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.